| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Sep―05 |
Bruton’s Tyrosine Kinase Inhibitors: A Versatile Therapeutic Approach for Cancer, Autoimmune Disorders, GVHD, and COVID-19 |
Swati Paliwal, Uma Agarwal, Rajiv Kumar Tonk |
| 2 |
[GO] |
2023―Sep―15 |
Ebselen: A Review on its Synthesis, Derivatives, Anticancer Efficacy and Utility in Combating SARS-COV-2 |
Farak Ali, Shahnaz Alom, Sheikh Rezzak Ali, Biswanarayan kondoli, Prativa Sadhu, Chinmoyee Borah, Bibhuti Bushan Kakoti, Surajit Kumar Ghosh, Anshul Shakya, Abdul Baquee Ahmed, Udaya Pratap Singh, Hans Raj Bhatt |
| 3 |
[GO] |
2023―Mai―04 |
Antiviral Flavonoids: A natural scaffold with prospects as phytomedicines against SARS-CoV2 |
Sandipan Chakraborty, Chiranjeet Saha, Roumi Naskar |
| 4 |
[GO] |
2023―Apr―18 |
A Review of Thyroid Dysfunction due to COVID-19 |
Alireza Arefzadeh |
| 5 |
[GO] |
2023―Mrz―27 |
Significance of Vitamin Supplementation in Reducing the Severity of COVID-19 |
Kota V Ramana, Myia Aiges |
| 6 |
[GO] |
2022―Nov―18 |
Gastrointestinal, liver, pancreas, oral and psychological long-term symptoms of COVID-19 after recovery; A review |
Shaban Alizadeh, Reza Afrisham, Yasaman Jadidi, Maryam Davoudi, Kiana Moayedi, Omid Soleimanifar, Chrysovalantou Eleni Xirouchaki, Damoon Ashtary-larky, Shadisadat Seyyedebrahimi |
| 7 |
[GO] |
2022―Okt―18 |
Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) |
Habeb Al-Kamel |
| 8 |
[GO] |
2022―Okt―18 |
Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19 |
Pan Luo |
| 9 |
[GO] |
2022―Okt―18 |
Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century |
Nitesh Sanghai |
| 10 |
[GO] |
2022―Okt―18 |
Possible Targets and Therapies of SARS-CoV-2 Infection |
Kasturi Sarkar |
| 11 |
[GO] |
2022―Jun―17 |
Targeting Virus-Induced Reprogrammed Cell Metabolism via Glycolytic Inhibitors: An Effective Therapeutic Approach Against SARS-CoV-2 |
Mamta Singh, Dolly Sharma, Rajat Gupta, Manoj Garg, Andrea Altieri, Alexander Kurkin, Vinit Kumar, Reshma Rani |
| 12 |
[GO] |
2022―Jun―06 |
Pathophysiology of SARS-CoV2 Mediated Depression, Therapeutics and Consequences: A Comprehensive Narrative |
Nikhat J. Siddiqi, B. Sharma |
| 13 |
[GO] |
2022―Mai―12 |
An Updated and Focused Review on Heterocyclic Inhibitors for SARS-CoV and SARS-CoV-2 3CLpro |
Ajay Manaithiya, Ozair Alam, Shruti Mittal, Mohd. Javed Naim, Mohd. Imran, Ahmed Subeh Alshrari, Aadil A. Sheikh, Imran A Khan |
| 14 |
[GO] |
2022―Mrz―30 |
The Immune Response to SARS-CoV-2: Mechanisms, Aging, Sequelae and Vaccines |
Carolina Espinoza, Marcelo Alarcón |
| 15 |
[GO] |
2022―Mrz―02 |
Antiviral Compounds Based on Natural ASTRAGALUS POLYSACCHARIDE (APS): Researches and Foresight in the Strategies for Combating SARS-CoV-2 (COVID-19) |
Elahe Aleebrahim Dehkordi, Ehsan Heidari-Soureshjani, Alisam Aryan, Zahra Ganjirad, Faezeh Soveyzi, Afsaneh Hoseinsalari, Mohamad Mehdi Derisi, Mahmoud Rafieian-Kopaei |
| 16 |
[GO] |
2022―Feb―02 |
SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics |
Shailendra Pratap Singh, Aayushi Bhatnagar, Sujeet Kumar Singh, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal, Salomon Amar, Ranata Manna |
| 17 |
[GO] |
2022―Jan―28 |
Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposed for Treatment of COVID-19 |
Nitin Tandon, Vijay Luxami, Runjhun Tandon, Kamaldeep Paul |
| 18 |
[GO] |
2022―Jan―13 |
Aptamers Against COVID-19: An Untested Opportunity |
Annekathrin Haberland, Johannes Müller |
| 19 |
[GO] |
2022―Jan―05 |
Thymoquinone: A Review of Pharmacological Importance, Oxidative Stress, COVID-19, and Radiotherapy |
Seyithan Taysi, Firas Shawqi Algburi, Zaid Mohammed, Omeed Akbar Ali, Muhammed Enes Taysi |
| 20 |
[GO] |
2022―Jan―05 |
Tuberculosis, BCG Vaccination and COVID-19: Are They Connected? |
Kellen Christina Malheiros Borges, Adeliane Castro da Costa, Lília Cristina de Souza Barbosa, Kaio Mota Ribeiro, Laura Raniere Borges dos Anjos, André Kipnis, Ana Paula Junqueira-Kipnis |
| 21 |
[GO] |
2021―Okt―28 |
The effect of plant metabolites on coronaviruses: A comprehensive review focusing on their IC50 values and molecular docking scores |
Parastou Farshi, Eda Ceren Kaya, Fataneh Hashempour-Baltork, Kianoush Khosravi-Darani |
| 22 |
[GO] |
2021―Aug―15 |
Synthetic Attempts Towards Eminent Anti-Viral Candidates of SARS-CoV |
Subhradip Kundu, Debayan Sarkar |
| 23 |
[GO] |
2021―Aug―06 |
The Promising Enzymes for Inhibitors Development against COVID-19 |
Zhi-Gang Sun, Feng-Ling Yu, Xiang-Ting Qiu, Shuang Li, Xue-Tang Li, Hai-Liang Zhu |
| 24 |
[GO] |
2021―Aug―06 |
Nature-derived hit, lead, and drug-like small molecules: Current status and future aspects against key target proteins of Coronaviruses |
Md. Junaid, Yeasmin Akter, Aysha Siddika, S. M. Abdul Nayeem, Afsana Nahrin, Syeda Samira Afrose, Md. Muzahid Ahmed Ezaj, Muhammad Shaiful Alam |
| 25 |
[GO] |
2021―Jun―30 |
Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19 |
Büşra Ünlü, Rahime Simsek, Selinay Başak Erdemli Köse, Anıl Yirün, Pinar Erkekoglu |
| 26 |
[GO] |
2021―Apr―23 |
RNA Coronaviruses’ Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics |
Ghadeer A. R. Y. Suaifan, Bayan A. Alkhawaja, Aya A. M. Mohammed |
| 27 |
[GO] |
2021―Apr―13 |
A therapeutic journey of potential drugs against COVID-19 |
Fayaz Ali, Shahid Hussain, Yi Zhun Zhu |
| 28 |
[GO] |
2021―Apr―02 |
Effectiveness of Azithromycin as add-on Therapy in COVID-19 Management |
Shadma Wahab, Md Faruque Ahmad, Arshad Hussain, Shazia Usmani, Ambreen Shoaib, Wasim Ahmad |
| 29 |
[GO] |
2021―Mrz―10 |
The situation of small molecules targeting key proteins to combat SARS-CoV-2: Synthesis, metabolic pathway, mechanism of action, and potential therapeutic applications |
Farzaneh Sorouri, Zahra Emamgholipour, Maryam Keykhaee, Alireza Najafi, Loghman Firoozpour, Omid Sabzevari, Mohammad Sharifzadeh, Alireza Foroumadi, Mehdi Khoobi |
| 30 |
[GO] |
2021―Feb―26 |
Elucidating the drug repurposing spectra of COVID-19 with its analogues SARS and MERS |
Jayanti Mishra, Chakrawarti Prasun, P.K. Sahoo, Maya S Nair |
| 31 |
[GO] |
2021―Feb―25 |
Treatment approaches for COVID-19: A critical review |
Nalini Sodum, Gautam Kumar, Vanishree Rao, Nitesh Kumar, Chamallamudi Mallikarjuna Rao |
| 32 |
[GO] |
2021―Feb―18 |
A review on Remdesivir: A broad-spectrum antiviral molecule for possible COVID-19 treatment |
Jabeena Khazir, Tariq Maqbool, Bilal Ahmad Mir |
| 33 |
[GO] |
2021―Feb―12 |
S.A.R.S Covid-19 A Medicinal Chemistry Approach |
Gautam Bhardwaj, Rajiv Kumar Tonk, Harish Garg, Vijay Bhalla |
| 34 |
[GO] |
2021―Feb―11 |
Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) |
Habeb Al-Kamel, Oliver Grundmann |
| 35 |
[GO] |
2021―Feb―04 |
Natural substances and semisynthetic derivatives as potential alternative products against SARS-CoV-2 |
Virginia Fuochi, Pio Maria Furneri |
| 36 |
[GO] |
2021―Jan―26 |
Coronavirus (COVID -19): Chemical entities of biological interest |
Aman Mahajan, Princy Gupta |
| 37 |
[GO] |
2021―Jan―05 |
A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19 |
Maheswara Rao Gokada, Visweswara Rao Pasupuleti, Hari Babu Bollikolla |
| 38 |
[GO] |
2020―Dez―29 |
Drug discovery of small molecules for the treatment of COVID-19: A review on clinical studies |
Bharat Goel, Nivedita Bhardwaj, Nancy Tripathi, Shreyans K. Jain |
| 39 |
[GO] |
2020―Dez―23 |
Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials |
Subha Sankar Paul, Goutam Biswas |
| 40 |
[GO] |
2020―Dez―18 |
A short review on important drugs under clinical trial against Covid-19 |
Namita Misra |
| 41 |
[GO] |
2020―Dez―05 |
Synthetic and semi-synthetic drugs as promising therapeutic option for the treatment of COVID-19 |
Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh C Sharma, Barij N Sinha, Harish Rajak |
| 42 |
[GO] |
2020―Nov―25 |
Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak |
Nitin Tandon, Vijay Luxami, Runjhun Tandon, Kamaldeep Paul |
| 43 |
[GO] |
2020―Nov―19 |
Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV-2 Infection (COVID-19) |
Surendra Kumar Nayak |
| 44 |
[GO] |
2020―Nov―13 |
Drug Re-purposing Approach and Potential Therapeutic Strategies to Treat COVID-19 |
Eeda Koti Reddy, Srisravanthi Battula, Shaik Anwar, Ayyiliath M Sajith |
| 45 |
[GO] |
2020―Okt―28 |
Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19 |
Pan Luo, Yi Liu, Dong Liu, Juan Li |
| 46 |
[GO] |
2020―Aug―24 |
Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century |
Nitesh Sanghai, Kashfia Shafiq, Geoffrey K. Tranmer |
| 47 |
[GO] |
2020―Aug―08 |
Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP |
Mohd. Faheem, Vinay K. Singh |
| 48 |
[GO] |
2020―Aug―08 |
Possible Targets and Therapies of SARS-CoV-2 Infection |
Kasturi Sarkar, Parames C. Sil, Seyed Fazel Nabavi, Ioana Beridan Neagoe, Cosmin Andrei Cismaru, Seyed Mohammad Nabavi, Solomon Habtemariam |
